Evidence map›Paper›PMID 16537625›Full record

ArticleJournal of virology2006

ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection.

Jenny Q Dai-Ju, Ling Li, Lisa A Johnson, Rozanne M Sandri-Goldin

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Widespread remodeling of the mProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jenny Q Dai-JuDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California at Irvine, Irvine, CA 92697-4025, USA.
Ling Li
Lisa A Johnson
Rozanne M Sandri-Goldin
University of California, Irvine · US

Funding

Herpes simplex virus gene regulationR37AI021515 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SANDRI-GOLDIN, ROZANNE M · 2002 to 2011
$3.8M
HERPES SIMPLEX VIRUS GENE REGULATIONR01AI021515 · NIAID · UNIVERSITY OF CALIFORNIA IRVINE · PI SANDRI-GOLDIN, ROZANNE M. · 1985 to 2001
$557k
NIAID NIH HHS AI21515NIAID NIH HHS R01 AI021515NIAID NIH HHS R37 AI021515
6 · The paper itself

Abstract

Herpes simplex virus 1 (HSV-1) ICP27 has been shown to interact with RNA polymerase II (RNAP II) holoenzyme. Here, we show that ICP27 interacts with the C-terminal domain (CTD) of RNAP II and that ICP27 mutants that cannot interact fail to relocalize RNAP II to viral transcription sites, suggesting a role for ICP27 in RNAP II recruitment. Using monoclonal antibodies specific for different phosphorylated forms of the RNAP II CTD, we found that the serine-2 phosphorylated form, which is found predominantly in elongating complexes, was not recruited to viral transcription sites. Further, there was an overall reduction in phosphoserine-2 staining. Western blot analysis revealed that there was a pronounced decrease in the phosphoserine-2 form and in overall RNAP II levels in lysates from cells infected with wild-type HSV-1. There was no appreciable difference in cdk9 levels, suggesting that protein degradation rather than dephosphorylation was occurring. Treatment of infected cells with proteasome inhibitors MG-132 and lactacystin prevented the decrease in the phosphoserine-2 form and in overall RNAP II levels; however, there was a concomitant decrease in the levels of several HSV-1 late proteins and in virus yield. Proteasomal degradation has been shown to resolve stalled RNAP II complexes at sites of DNA damage to allow 3' processing of transcripts. Thus, we propose that at later times of infection when robust transcription and DNA replication are occurring, elongating complexes may collide and proteasomal degradation may be required for resolution.

Indexed as

Transcription, GeneticAmino Acid SequenceAnimalsAntibodies, MonoclonalBlotting, WesternCysteine Proteinase InhibitorsEpithelial CellsFibroblastsFluorescent Antibody TechniqueGlutathione TransferaseHeLa CellsHerpesvirus 1, HumanHumansImmediate-Early ProteinsLeupeptinsMicroscopy, FluorescenceAntibodies, Monoclonalbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCysteine Proteinase InhibitorsGlutathione TransferaseICP27 protein, human herpesvirus 1Immediate-Early ProteinsLeupeptinsProteasome Endopeptidase ComplexRNA Polymerase II

Identifiers

PMID16537625
PMCPMC1440381
OpenAlexW2117645968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.